Chinese Journal of Practical Pediatrics ›› 2024, Vol. 39 ›› Issue (3): 168-174.DOI: 10.19538/j.ek2024030602

Previous Articles     Next Articles

Treatment strategies for child cardiomyopathy (2023 edition): Interpretation of an American Heart Association scientific statement

  

  1. Children’s Hospital,Zhejiang University School of Medicine;National Clinical Research Center for Child Health,Hangzhou  310052,China
  • Online:2024-03-06 Published:2024-03-14

2023版儿童心肌病的治疗策略:美国心脏协会科学声明的解读

  

  1. 浙江大学医学院附属儿童医院  国家儿童健康与疾病临床医学研究中心,浙江  杭州  310052 
  • 通讯作者: 张晨美, 电子信箱:chzcm@zju.edu.cn
  • 基金资助:
    国家重点研发计划(2021YFC2701800;2021YFC2701801) 

Abstract: In 2023, the American Heart Association(AHA) issued a scientific statement on the treatment strategies for child cardiomyopathy, focusing on dilated and hypertrophic cardiomyopathies, which addresses the lack of treatment options for children-specific cardiomyopathies and provides options based on the AHA perspective. The purpose of this paper is to interpret this scientific statement in order to provide an AHA-based decision-making evidence for domestic colleagues to develop treatment programs for children with cardiomyopathies.

Key words: cardiomyopathy, child, American Heart Association, scientific statement, expert consensus, guidelines

摘要: 2023年美国心脏协会(AHA)发布了儿童心肌病治疗策略的科学声明,重点介绍扩张型和肥厚型心肌病的治疗策略,解决了目前缺乏儿童特有的心肌病的治疗方案问题,给出了基于AHA观点的方案。文章旨在通过解读该科学声明,为国内同行针对心肌病患儿制订治疗方案时提供基于AHA观点的决策依据。

关键词: 心肌病, 儿童, 美国心脏协会, 科学声明, 专家共识, 指南